BriaCell Therapeutics (NASDAQ:BCTX) Receives Buy Rating from HC Wainwright
BriaCell Therapeutics (NASDAQ:BCTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $32.00 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 489.32% from the stock’s current price. BriaCell Therapeutics […]
BriaCell Therapeutics (NASDAQ:BCTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $32.00 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 489.32% from the stock’s current price. BriaCell Therapeutics […]
